For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...

A new set of drugs exploit a recently revealed weakness in "zombie-like"—or senescent—cells that could lead to new treatments ...

Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...

It may be possible to identify which pre-cancerous cells will develop into a rare type of blood cancer, due to new research ...

The stiffness of tumour tissue plays a role in how cancer spreads. Furthermore, stiff tumour tissue leaves traces in the ...

Researchers at the University of Colorado Anschutz may have identified why many cancer patients say food suddenly tastes ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

Scientific Advisory Board (SAB) includes experts in the development and approved T-cell engager therapies, supporting CAPTN-3 ...

In the ongoing development of cancer immunotherapy, as well as our still developing understanding of the human immune system, ...